Molecular Pharmacology (USA), Ltd. (MLPH)の価格はいくらですか

Molecular Pharmacology (USA), Ltd. (MLPH)の価格は$0.0322です

Molecular Pharmacology (USA), Ltd. (MLPH)の時価総額は何ですか

Molecular Pharmacology (USA), Ltd. (MLPH)の時価総額は$643.71Kです

Molecular Pharmacology (USA), Ltd.（MLPH）配当金

As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is dedicated to the creation and market introduction of solutions for pain and inflammation, with a primary focus on the Australian and United States markets. Through its subsidiary, Molecular Pharmacology Pty. Ltd., it is advancing an analgesic and anti-inflammatory molecule called Tripeptofen, designed to alleviate common daily pain. These products are offered in diverse dosage forms, formulations, and packaging options to suit various needs. MLPH's marketing strategy involves leveraging pharmaceutical distributors and forging collaborative partnerships with companies in the United States and Europe. Additionally, the company maintains an agreement with Dermatology Development Corporation to jointly develop and market a suite of therapeutic, cosmetic, and cosmeceutical items derived from the ThermaLIFE product line and its core active component. Headquartered in Perth, Australia, Molecular Pharmacology (USA) Limited operates as a subsidiary of PharmaNet Group Limited.

年	配当（株式分割調整済み）	変化
提供された日付のデータは十分ではありません。

年

配当（株式分割調整済み）

変化

提供された日付のデータは十分ではありません。

年	配当	変化
提供された日付のデータは十分ではありません。

年

配当

変化

提供された日付のデータは十分ではありません。

企業	配当支払い回数	国
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Lonza Group AG LONN.SW	0.00%	CH
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	KR
UCB S.A. UCB.BR	29.00%	BE

企業

配当支払い回数

国